

Amarin Corporation (NASDAQ: AMRN) shares are trading higher Tuesday after the company announced a long-term exclusive license and supply agreement with...
You can purchase shares of Amarin Corp (NASDAQ:AMRN) through any online brokerage.
Other companies in Amarin Corp’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Amarin Corp has a consensus price target of $12.50.
The stock price for Amarin Corp (NASDAQ: AMRN) is $12.34 last updated October 28, 2026 at 8:37 AM EDT.
There are no upcoming dividends for Amarin Corp.
Amarin Corp does not have any upcoming earnings scheduled.
There is no upcoming split for Amarin Corp.
Amarin Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses...